AzTrials
AzTrials

HIVNCT02733692

Culturally Congruent HIV Risk Reduction App for Young Women, an Acceptability & Pilot Evaluation

A study testing Understanding Reproductive Health for Ladeez (GURHL) Code in people with HIV and STDs, run by City University of New York, School of Public Health at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Smartphone applications and mobile technologies offer users the potential to access critical information (e.g., proper condom use, directions to testing sites, and other sexual and reproductive health services) when it is needed most. Read more about this study

Who is it for?
Ages 18 to 25 years, women onlyHealthy volunteers can take part
Conditions the study is for
HIV, STDs
What is being tested?
Understanding Reproductive Health for Ladeez (GURHL) Code
Could I receive a placebo?
No, everyone receives an active treatment
How many people
110 participants
Where
1 siteUnited States
Study dates
Jul 2015to Jun 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 25 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • women between 18 and 25 years old;
  • self-identify as either Black and/or Latina;
  • own a smartphone (iOS or android);
  • live in NYC;
  • report vaginal or anal intercourse in their lifetime;
  • report unprotected intercourse in their lifetime;
  • healthy (not controls) adults. There will be estimated total 110 of said subjects.

Who cannot join

  • being married or partnered for more than one year,
  • report only being sexually active with women,
  • pregnant or have children 2 years old or younger,
  • HIV+ status,
  • men,
  • individuals under 18 and over 25,
Show all 9Show fewer
  • live in a place other than New York City,
  • formal training as a sexual peer health educator (beyond a high school health class) or
  • unable to read English.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • CUNY

    New York, New York, 10027

Other trials in United States

About this study

Smartphone applications and mobile technologies offer users the potential to access critical information (e.g., proper condom use, directions to testing sites, and other sexual and reproductive health services) when it is needed most. Relevant findings will identify areas where existing interventions may be leveraged and adapted to work among young women of color in an urban setting and their networks. As SRH smartphone apps continue to proliferate, this study will expand researchers', developers', and health educators' limited knowledge about the feasibility, acceptability and preliminary efficacy of a sexual health educational app tailored with and for young Black and Latino women, aged 18-25 in NYC, including whether this app acts as a gateway to sexual health educators, clinical and other service providers. If proven effective, findings from this study will identify areas where existing interventions may be leveraged and adapted to work among a YBLW and their networks, and potentially adapted for other high needs communities.

Read the detailed description

New HIV, Chlamydia and Gonorrhea infections are highest among young Black women and Latinas aged 13 to 29 years old compared to White women, which negatively impacts other sexual and reproductive health outcomes. Given that young women have a substantial need for SRH services and a high smartphone ownership, unique opportunities to utilize mobile apps(applications) to decrease HIV risk behaviors may exist.

A tailored, culturally congruent, smartphone app co-developed with and for young Black and Latino women (18 to 25 years old) not yet publicly available offers a unique opportunity to conduct a feasibility, acceptability, and pilot RCT. Using this app, this pilot that will: a) assess feasibility of the sampling, consent, recruitment and retention techniques; b) collect acceptability and usability data and cultural congruence on the app; a and c) collect pilot data to test differences between intervention and control groups on the preliminary estimates of app effectiveness to inform a potential larger-scale study. The investigators propose YBLW between 18 and 25 years old in NYC will use a mobile-based health education app to access SRH education information. Additionally, those who use the tailored SRH app will have more self-reported connection to SRH services, better knowledge of SRH education domains, and how to link to clinical services (e.g., PREP, PEP, EC, birth control, HIV, STD, and pregnancy testing), compared to the control group. Analysis for the first aim will employ process measures and the second and third aims are mixed-methods aims.

Analysis will compare differences between the 2-arms and indiscernible differences and culturally tailored usability will be explored via focus groups and web analytics.

Conditions
HIV, STDs
Being tested
Understanding Reproductive Health for Ladeez (GURHL) Code
Keywords
HIV, STDs, web-based app, women
Medical subject headings
Sexually Transmitted Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Understanding Reproductive Health for Ladeez (GURHL) CodeBehavioural

    Understanding Reproductive Health for Ladeez (GURHL) Code is an acceptability study to test a web-based application designed with and for young women of color 18 to 25 years old.

Study groups in NCT02733692
Study groupRoleWhat they receive
GURHL Code Smartphone applicationExperimentalExperimental arm will receive the 'Understanding Reproductive Health for Ladeez (GURHL) Code 'app' (application) for their smartphone with sexual health information. The intervention is embedded in the smart phone application. This includes sexual and reproductive health knowledge, plus access to a National Planned Parenthood health educator, and directions to other nearby clinics. Participants will be assessed using A-CASI at 3 months after enrollment.
Receives: Behavioral: Understanding Reproductive Health for Ladeez (GURHL) Code
ControlNo interventionThe control arm will receive usual care. That is, they will receive a web-based flyer. This flyer will include a list of clinics and other trusted available resources, but without hyperlinks. Participants will be assessed using A-CASI at 3 months after enrollment.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Preliminary Efficacy1 Improvement in Sexual Health Knowledge Condom Use

    Effectiveness of the app based on reported knowledge of where to get condoms and how to use properly.

    Measured: 3 months

  2. Preliminary Efficacy 2 Improvement in Sexual Health Knowledge Sexual and Reproductive Health Services

    Effectiveness of the app based on reported knowledge of what sexual and reproductive health services exist and where to access them

    Measured: 3 months

  3. Preliminary Efficacy 2 Improvement in Sexual Health Knowledge HIV and STD

    Effectiveness of the app based on reported knowledge of what behaviors increase the risk for HIV and other sexually transmitted diseases

    Measured: 3 months

  4. Preliminary Efficacy 3 Improvement in Sexual Health Knowledge Connection to Services

    Effectiveness of the app based on reported knowledge of connection to sexual and reproductive health clinical services, based on whether women communicated with a reproductive health educator and whether she sought sexual and reproductive health services in person.

    Measured: 3 months

Secondary outcomes (7)
  1. Usability 1 Number of Times Used

    The usability of the app will be determined by the number of times the app is opened

    Measured: 3 months

  2. Usability 2 Actions Taken

    The usability of the app will be determined by the actions users take during sessions (each action coded as positive regardless of which one, including other links clicked on, audio listened to or video links clicked on)

    Measured: 3 months

  3. Usability 3 Duration

    The usability of the app will be determined by the duration of page visits

    Measured: 3 months

  4. Usability 4A App performance

    The usability of the app will be determined by the number of technical errors encountered by users.

    Measured: 3 months

  5. Usability 4B Ease of App usage

    The usability of the app will be determined by the ease of usage and if users liked and understood the contents

    Measured: 3 months

  6. Usability 5 Facilitators and Barriers

    The usability of the app will be determined by user reports of facilitators and barriers to usage.

    Measured: 3 months

  7. Usability 6 User Friendliness

    The usability of the app will be determined by the users' assessment of usefulness, trustworthiness and usability

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Apr 2016 (estimated)
  2. Study startJul 2015
  3. Primary completionApr 2016
  4. Study completionJun 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
110 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02733692
Sponsor's protocol ID
381039
Status last verified
Jul 2017
First submitted
11 Jan 2016
Last updated
25 Aug 2017
Results posted
No
Data monitoring committee
Yes
Individual data sharing
No: The data collected and used ofr this will not be made publicly available.

Questions about this trial

What is this clinical trial studying?

A study testing Understanding Reproductive Health for Ladeez (GURHL) Code in people with HIV and STDs, run by City University of New York, School of Public Health at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Aug 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Preliminary Efficacy1 Improvement in Sexual Health Knowledge Condom Use (time frame: 3 months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Aug 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in